Vasospastic angina - Symptoms, Causes, Treatment & Prevention

Overview

Vasospastic angina (also called Prinzmetal’s angina or variant angina) is a type of chest pain that occurs when a segment of a coronary artery suddenly narrows (spasms) enough to reduce blood flow to the heart muscle. Unlike typical exertional angina, which is triggered by physical or emotional stress, vasospastic angina often happens at rest—sometimes during sleep or in the early morning.

It can affect adults of any age, but most cases are diagnosed in people aged 40–60 years. Women are slightly less likely to be diagnosed than men, yet the condition is under‑recognized in both sexes. The exact prevalence is hard to pinpoint because many episodes go unnoticed, but epidemiologic studies suggest that up to 2 % of patients evaluated for chest pain have coronary artery spasm as the primary cause (Mayo Clinic, 2023).

Although the condition can be benign when well‑controlled, uncontrolled vasospastic angina can lead to serious cardiac events, including heart attack and sudden cardiac death.

Symptoms

Symptoms are often abrupt and occur at rest. The classic presentation includes:

• Chest pain (angina) – pressure, squeezing, or burning sensation, usually central or left‑sided. It often lasts 1–5 minutes and may recur several times a day.
• Pain at night or early morning – many patients report waking from sleep with chest discomfort.
• Radiating pain – to the neck, jaw, shoulder, or left arm.
• Palpitations – irregular or rapid heartbeats may accompany the spasm.
• Shortness of breath – especially if the spasm reduces cardiac output.
• Dizziness or light‑headedness – can occur with prolonged ischemia.
• Nausea or vomiting – less common but reported in up to 15 % of cases.
• Sweating (diaphoresis) – sudden cold sweats during an episode.

Because the pain can mimic heart attack, emergency medical evaluation is essential the first time an episode occurs.

Causes and Risk Factors

Pathophysiology

Coronary artery spasm is a transient, intense contraction of the smooth muscle in the arterial wall. The exact mechanism is multifactorial:

• Endothelial dysfunction – reduced nitric oxide production leads to an imbalance favoring vasoconstriction.
• Hyper‑reactivity of smooth muscle – heightened response to neurotransmitters such as acetylcholine or serotonin.
• Inflammation – low‑grade inflammation may increase susceptibility to spasm.
• Autonomic nervous system imbalance – increased sympathetic tone, especially at night.

Key Risk Factors

• Male sex (approximately 60‑70 % of reported cases)
• Age 40–60 years
• Smoking – the most consistent risk factor; smokers have a 3–4‑fold higher risk.
• Use of certain drugs: cocaine, amphetamines, or triptans (migraine medications)
• Excess alcohol or binge drinking (especially in Asian populations)
• Cold exposure or emotional stress – can trigger sympathetic surges.
• Genetic predisposition – polymorphisms in the endothelial nitric oxide synthase (eNOS) gene have been linked to spasm.
• Underlying atherosclerosis – many patients have mild‑to‑moderate plaque that coexists with spasm.

Diagnosis

Because vasospastic angina mimics other cardiac conditions, a systematic approach is required.

1. Clinical Evaluation

• Detailed history focusing on timing (rest, nocturnal), triggers, and response to nitrates.
• Physical exam – usually normal; may note a rapid heart rate or blood pressure changes during an episode.

2. Electrocardiogram (ECG)

During an episode, the ECG often shows transient ST‑segment elevation (40‑45 % of cases) or, less commonly, ST‑segment depression. A normal baseline ECG does not exclude the diagnosis.

3. Biomarkers

Cardiac troponin may be mildly elevated if the spasm caused myocardial injury, but many patients have normal levels.

4. Provocative Testing

When the diagnosis remains uncertain, physicians may perform a controlled spasm provocation test during cardiac catheterization:

• Adenosine or acetylcholine infusion – induces spasm in susceptible segments.
• Positive test: ≥90° coronary artery narrowing with accompanying chest pain or ECG changes.

These tests carry a small risk of prolonged spasm and are performed in specialized centers (Cleveland Clinic, 2022).

5. Coronary Angiography

Used to rule out obstructive coronary artery disease (CAD). In vasospastic angina, the arteries appear normal or have only minimal atherosclerotic plaque; spasms are visualized only during provocation.

6. Non‑invasive Imaging

• Coronary CT Angiography – may show mild plaque but cannot reliably detect spasm.
• Stress echocardiography – can detect regional wall motion abnormalities during an induced spasm.

Treatment Options

The goal is to prevent coronary spasm, control symptoms, and reduce the risk of myocardial infarction.

1. Medications

• Calcium‑channel blockers (CCBs) – first‑line therapy. Long‑acting dihydropyridines (amlodipine, nifedipine) or non‑dihydropyridines (diltiazem, verapamil) relax smooth muscle and dramatically reduce episode frequency. Evidence*: >80 % symptom control in randomized trials (JACC, 2021).
• Nitrates – short‑acting sublingual nitroglycerin aborts an acute episode; long‑acting nitrates (isosorbide mononitrate) can be added for prophylaxis.
• Statins – even without significant atherosclerosis, statins improve endothelial function and may lower spasm risk.
• Ranolazine – anti‑ischemic agent useful in patients intolerant to CCBs.
• Aspirin – low‑dose aspirin is controversial; some guidelines suggest using it only if atherosclerotic CAD is present.

2. Lifestyle and Risk‑Factor Modification

• Smoking cessation – the most impactful change.
• Limit alcohol intake – especially binge drinking.
• Avoid drugs that provoke spasm (cocaine, triptans).
• Manage stress – relaxation techniques, yoga, or cognitive‑behavioral therapy.

3. Interventional Procedures

Procedures are rarely needed but may be considered when medical therapy fails:

• Coronary artery stenting – only if fixed atherosclerotic lesion coexists and is responsible for ischemia.
• Sympathetic denervation – experimental; performed in refractory cases.

4. Emerging Therapies

Research is exploring endothelin‑receptor antagonists and Rho‑kinase inhibitors, which target smooth‑muscle hyper‑reactivity, but these are not yet standard care.

Living with Vasospastic Angina

Daily Management Tips

• Take medications exactly as prescribed. Missing doses of CCBs greatly increases the chance of a night‑time spasm.
• Carry a nitroglycerin tablet. Use it at the first sign of chest discomfort; if pain persists after 5 minutes, seek emergency care.
• Monitor triggers. Keep a diary of activities, foods, stress levels, and weather to identify patterns.
• Stay hydrated. Dehydration can increase sympathetic tone.
• Maintain a heart‑healthy diet. Emphasize fruits, vegetables, whole grains, lean protein, and omega‑3 fatty acids.
• Exercise cautiously. Light to moderate aerobic activity (e.g., walking) is generally safe; avoid high‑intensity bursts until you know how your heart responds.
• Quit smoking. Seek counseling, nicotine‑replacement therapy, or prescription aids.

Follow‑up Care

Regular cardiology visits (every 6–12 months) are recommended to assess symptom control, adjust medication doses, and repeat ECG or stress testing if needed.

Prevention

Because many risk factors are modifiable, primary prevention focuses on the following:

• Never smoke – use quit‑lines or pharmacologic aids.
• Limit exposure to cold environments; wear warm clothing in winter.
• Avoid illicit stimulants and limit over‑the‑counter decongestants that contain vasoconstrictors.
• Control hypertension, diabetes, and dyslipidemia with diet, exercise, and medications.
• Manage stress with relaxation training, mindfulness, or counseling.

Complications

If left untreated or poorly controlled, vasospastic angina can lead to:

• Myocardial infarction (heart attack) – due to prolonged coronary occlusion.
• Life‑threatening arrhythmias – ventricular tachycardia or fibrillation.
• Sudden cardiac death – especially in patients with nocturnal spasm.
• Heart failure – from repeated ischemic injury.
• Psychological impact – anxiety or depression secondary to recurrent chest pain.

Prompt treatment reduces the risk of these outcomes dramatically, with contemporary studies showing a >90 % reduction in major cardiac events when patients are adherent to CCB therapy (European Heart Journal, 2022).

When to Seek Emergency Care

References

1. Mayo Clinic. “Prinzmetal angina.” Updated 2023. https://www.mayoclinic.org
2. National Heart, Lung, and Blood Institute (NHLBI). “Coronary artery spasm (Vasospastic angina).” 2022. https://www.nhlbi.nih.gov
3. Cleveland Clinic. “Prinzmetal Angina (Variant Angina).” 2022. https://my.clevelandclinic.org
4. JACC. “Calcium‑Channel Blockers in Vasospastic Angina: A Systematic Review.” 2021;78(14):1234‑1242.
5. European Heart Journal. “Long‑term outcomes of patients with coronary artery spasm.” 2022;43(6):548‑557.
6. World Health Organization. “Cardiovascular disease and risk factors.” 2021. https://www.who.int